NDA 021128 · Kenvue Brands
Children'S Motrin Cold
Ibuprofen, Pseudoephedrine Hydrochloride · Oral
Last checked: Nov 19, 2026Latest source record: Apr 3, 2017 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2000
Aug 1, 2000
Approved uses
1
Original approval plus efficacy supplements
Registered trials
910
162 Phase 3, 61 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Aug 1, 2000 Original approval · Type 3 - New Dosage Form Review
1 products under this application
- CHILDREN'S MOTRIN COLD · IBUPROFEN 100MG/5ML; PSEUDOEPHEDRINE HYDROCHLORIDE 15MG/5ML · SUSPENSION, ORAL · Over-the-counter
Clinical trials
Interventional ClinicalTrials.gov studies with "Ibuprofen" as an intervention, any sponsor and status, largest first.
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenPivotal-lookingCompleted
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Pfizer (PFE)
NCT00346216 · 24,081 participants · Start Oct 4, 2006 · Primary completion Apr 12, 2016
Drug: celecoxib; Ibuprofen and 1 more · For: Arthritis, Rheumatoid
Sites: Alabaster, Alabama; Bessemer, Alabama; Birmingham, Alabama · 1,066 sites in all
- The Standard Care Versus Celecoxib Outcome TrialPivotal-lookingCompleted
University of DundeeAcademic, hospital or other
NCT00447759 · 7,297 participants · Start Jun 2007 · Primary completion Aug 2015
Drug: Celecoxib; Diclofenac · For: Osteoarthritis; Rheumatoid Arthritis
Sites: Odense, Denmark; Zeist, Netherlands; Aberdeen, United Kingdom · 10 sites in all
- A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth DiseasePivotal-lookingCompleted
The First Affiliated Hospital of Anhui University of Traditional Chinese MedicineAcademic, hospital or other
NCT01182532 · 3,000 participants · Start May 2010 · Primary completion Oct 2011
Drug: TCM Syndrome Differentiation and Treatment · For: Hand, Foot and Mouth Disease
Sites: Hefei, China; Beijing, China; Chongqing, China · 21 sites in all
- Safety of Ibuprofen After Major Orthopaedic SurgeriesPivotal-lookingCompleted
Naestved HospitalAcademic, hospital or other
NCT05575700 · 2,904 participants · Start Apr 17, 2023 · Primary completion Aug 19, 2025
Drug: Ibuprofen; Placebo · For: Pain, Acute; Hip Arthropathy; Knee Arthropathy and 5 more
Sites: Brøndby, Denmark; Copenhagen NV, Denmark; Farsø, Denmark · 11 sites in all
- Use of Ibuprofen to Prevent IUD Site EffectsPivotal-lookingCompleted
FHI 360Academic, hospital or other
NCT00243815 · 2,019 participants · Start Jun 2002
Drug: ibuprofen · For: IUD Removal
Sites: Santiago, Chile
- Opioid Analgesic Reduction StudyPivotal-lookingCompleted
Rutgers, The State University of New JerseyAcademic, hospital or other
NCT04452344 · 1,815 participants · Start Jan 4, 2021 · Primary completion Jul 7, 2023
Drug: opioid-containing analgesic; two over-the-counter analgesics · For: Opioid Use
Sites: Chicago, Illinois; Baltimore, Maryland; Ann Arbor, Michigan · 5 sites in all
- Prehospital Analgesia in Adults Using Inhaled Methoxyflurane StudyPivotal-lookingStatus unknown
Ottawa Hospital Research InstituteAcademic, hospital or other
NCT06392087 · 1,800 participants (planned) · Start Aug 1, 2024 · Primary completion Mar 1, 2025
Drug: Methoxyflurane · For: Pain, Acute
- Perioperative Inflammation and Breast Cancer OutcomePivotal-lookingStatus unknown
Samsung Medical CenterAcademic, hospital or other
NCT02141139 · 1,568 participants (planned) · Start Sep 2014 · Primary completion Jan 2016
Drug: NSAIDS (ketorolac and ibuprofen) · For: Breast Neoplasms
Sites: Seoul, South Korea
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Short-term Dual Therapy or Mono Therapy With Acetaminophen and Ibuprofen for Fever: A Network Meta-Analysis.
De la Cruz-Mena JE, Veroniki AA, Acosta-Reyes J, et al. · Pediatrics 2024 · Systematic Review, Network Meta-Analysis
- Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis.
Tan E, Braithwaite I, McKinlay CJD, et al. · JAMA Netw Open 2020 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Single-Blind Randomized Controlled Trial: Comparative Efficacy of Dark Chocolate, Coconut Water, and Ibuprofen in Managing Primary Dysmenorrhea.
Nuha K, Rusmil K, Ganiem AR, et al. · Int J Environ Res Public Health 2023 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Paracetamol versus ibuprofen in treating episodic tension-type headache: a systematic review and network meta-analysis.
Alnasser A, Alhumrran H, Alfehaid M, et al. · Sci Rep 2023 · Systematic Review, Network Meta-Analysis
- Acupuncture for lumbar disc herniation: a systematic review and meta-analysis.
Tang S, Mo Z, Zhang R · Acupunct Med 2018 · Meta-Analysis, Systematic Review
- The impact of the route of administration on the efficacy and safety of the drug therapy for patent ductus arteriosus in premature infants: a systematic review and meta-analysis.
Luo H, He J, Xu X, et al. · PeerJ 2024 · Meta-Analysis, Systematic Review
Sponsor: Kenvue Brands
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.